Illumina公司，基因组学研究领域的技术与市场领导者。借助新一代测序（NGS）与基因芯片（MicroArray）技术与平台，秉承“解锁基因组奥秘，推动人类健康事业”的愿景，为全球科研、医疗、制药、公共卫生等领域提供基因组学完整解决方案。Illumina公司主要提供Sequencing Kits、Library Preparation Kits、Cluster Generation & Sequencing Reagents、Microarray Kits、Clinical Research Products和Informatics Products等类型的产品。

Illumina的主要产品包括：

（1）Browse by Area of Interest:

Cancer Genomics Products

Reproductive Health Products

Microbial Genomics Products

Complex Disease Genomics Products

Genetic Health Products

Forensic Genomics Products

Agrigenomics Products

Genomics in Drug Development Products

（2）Browse by System:

HiSeq 2500 Products

HiSeq 3000/HiSeq 4000 Products

HiSeq X Five/HiSeq X Ten Products

iScan Products

iSeq Products

MiniSeq Products

MiSeq Products

MiSeqDx Products

MiSeq FGx Products

NextSeq Products

NovaSeq Products

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Nexcelom品牌。

2003年，Nexcelom的创始人推出了CP2，这是一种辅助手动细胞计数的方便工具。Nexcelom的创始人兼首席技术官JeanQiu博士说，“NIH的某位客户曾要求我们‘消除显微镜计数’。

为此，我们发明了CellometerAutoT4，用于测量细胞浓度和活力。”自那时起，Nexcelom扩大了产品范围，升级了系统功能，并优化了适用的方法，使研究人员能够分析所有细胞类型，

包括小细胞和原代细胞。凭借先进的专有技术，Nexcelom是细胞分析中基于图像的细胞计数的领导者和创新者。世界各地的科学家在学术和政府研究机构、生物技术和工业环境中使用

Cellometer，Cellaca和Celigo仪器进行细胞定量、分析和基于细胞的检测。Nexcelom图像细胞术和细胞分析解决方案被集成到生命科学的广泛工作流程中。